News - Bavarian Nordic
Sep 24, 2024 · Bavarian Nordic Announces FDA Acceptance and Priority Review of the BLA for its Chikungunya Vaccine. August 08, 2024 | Company Announcements. Bavarian Nordic …
News | Bavarian Nordic
Sep 19, 2024 · Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents. MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after …
News - Bavarian Nordic
Sep 20, 2022 · During the ongoing 2022 outbreak of monkeypox, Bavarian Nordic has worked with several governments to fulfil the immediate demand for the vaccine through a number of …
News | Bavarian Nordic
Aug 16, 2024 · Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents. Interim results from clinical study show non-inferiority of immune …
News | Bavarian Nordic
Oct 29, 2024 · First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine. Clinical study in children 2-11 years of age follows the …
News | Bavarian Nordic
Bavarian Nordic Announces U.S. FDA Approval of JYNNEOS™ (Smallpox and Monkeypox Vaccine, Live, Non-replicating) for Prevention of Smallpox and Monkeypox Disease in Adults. …
News | Bavarian Nordic
Jun 26, 2024 · Recent data 1 suggest that chikungunya is severely underreported and often misdiagnosed as dengue fever due to lack of proper testing. About Bavarian Nordic. Bavarian …
News | Bavarian Nordic
Aug 22, 2024 · Bavarian Nordic Announces First Half 2024 Results. COPENHAGEN, Denmark, August 22, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial …
News | Bavarian Nordic
Sep 12, 2024 · Bavarian Nordic has informed Gavi and UNICEF that by focusing the full capacity to address the current public health emergency, the Company could supply up to 13 million …
News | Bavarian Nordic
Sep 18, 2024 · Gavi Signs Agreement with Bavarian Nordic to Rapidly Secure 500,000 Doses of Mpox Vaccines for Africa. The advance purchase agreement (APA) will be funded by Gavi’s …